Product Information
CAPTOPRIL 12.5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.2477 per EA under NDC 00904710561. Its NADAC has been published 254 times since Aug 18, 2021.
Strength
12.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904710561
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CAPTOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA212809On Market Since
12/13/2019
Pharmacological Classes
Price Statistics
The NADAC for CAPTOPRIL 12.5 MG TABLET has been published 254 times since Aug 18, 2021, and over the history we have for it it has declined 40.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2477 per EA |
|---|---|
| All-time high | $0.6898 (Apr 10, 2024) |
| All-time low | $0.1816 (Mar 19, 2025) |
| 52-week high | $0.4059 |
| 52-week low | $0.2477 |
| Median price | $0.4109 |
| Average price | $0.4077 |
| Largest weekly change | +125.8% (Aug 17, 2022) |
| Weeks tracked | 254 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAPTOPRIL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 12.5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.2477 per EA (NDC 00904710561), effective Jun 24, 2026.
How has the price of CAPTOPRIL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPTOPRIL 12.5 MG TABLET has declined 40.9%. It has been tracked across 254 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for CAPTOPRIL 12.5 MG TABLET?
Since Aug 18, 2021, the NADAC for CAPTOPRIL 12.5 MG TABLET has ranged from a low of $0.1816 (Mar 19, 2025) to a high of $0.6898 (Apr 10, 2024), with a median of $0.4109 per EA.
Are there cheaper alternatives to CAPTOPRIL 12.5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CAPTOPRIL 12.5 MG TABLET, but none are currently priced below it.
Who manufactures CAPTOPRIL 12.5 MG TABLET?
CAPTOPRIL 12.5 MG TABLET (NDC 00904710561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification